Due: May 15, 2024
The 2024 RETpositive/LUNGevity Translational Research Award Program for RET-positive Cancer program is now open for application submissions. The program is expected to have a direct impact on the outcomes of patients with advanced RET-positive cancer. All application materials must be submitted electronically via proposalCENTRAL.:
Due: Nov 7, 2024
Due: Mar 16, 2025
Due: May 7, 2026